FREMONT, CA -- (Marketwire) -- 09/02/08 -- Cardima, Inc. (OTCBB: CADM), a medical device
company focused on the treatment of Atrial Fibrillation ("AF") and
manufacturer of the Cardima Surgical Ablation System and the REVELATION®
line of therapeutic electrophysiology catheters, has commenced training
physicians in Thailand on the use of the Cardima Surgical Ablation System.
The training on August 22-25, 2008 was performed under the direction of Dr.
Li Poa. He worked closely with Dr. Suchart Chaiyaroj, Chief of
Cardiothoracic Surgery, and his associate Dr. Khanat Kruthkul, at
Ramathibodi Hospital. A total of four patients to date have been
successfully ablated using the Cardima Surgical Ablation System.
"The training session here in Thailand went extremely well. The Thai
surgeons at Ramathibodi Hospital were extremely supportive of this effort
and very impressed with the performance of the Cardima product and its
ability to create deep lesions," stated Dr. Poa. "Surgeons from leading
Thai medical institutions attended and we are now on our way to
establishing a core team of highly proficient surgeons capable of treating
atrial fibrillation using the Cardima products."
Dr. Suchart Chaiyaroj commented on behalf of Ramathibodi Hospital and the
Thai physicians participating in the program, "This training program and
the development of an AF Center of Excellence in Thai medical facilities is
a tremendous development for both our domestic health system and our
medical tourism program. We very much appreciate the support of Dr. Li
Poa, MEDS Global Healthcare, and Cardima in establishing this program. Dr.
Khanat Kruthkul, the other physicians who attended and I were very
impressed with the Cardima Surgical Ablation System. We look forward to
improving the health of many patients once this surgical ablation program
is fully launched and we start treating AF patients effectively here in
Thailand in large numbers. With the Cardima Surgical System we can now work
effectively together with our EP colleagues and offer treatment for stand
alone AF."
Several institutions and individuals have provided significant levels of
support to this new program to develop Thailand as a Center of Excellence
for the treatment of Atrial Fibrillation; in particular, the cardiology
faculty at Ramathibodi Hospital, which is associated with Mahidol
University, Dr. Li Poa, Dr. Suchart Chaiyaroj, Chief of Cardiothoracic
Surgery at Ramathibodi Hospital, Dr. Khanat Kruthkul, the Thai Ministry of
Health, MEDS Global Healthcare USA, the Thai Finance Ministry, DKSH
Diethelm Ltd., as well as Cardima.
"We need to give a lot of credit to Dr. Li Poa and to the Thai physicians
who worked closely to get this training session under way so quickly and to
all the companies and institutions that provided support.
